Stay updated on CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab

Sign up to get notified when there's something new on the CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab page.
Latest website image capture
Clouds background image

Latest updates to the CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab page

  1. Check
    yesterday
    Change Detected
    Summary
    The page revision updated from v3.3.3 to v3.3.4. No visible changes to study details, eligibility criteria, or other core content.
    Difference
    0.0%
    Check dated 2026-01-16T11:53:17.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Added a dedicated Locations section listing Kansas and Pennsylvania sites and updated the page to revision v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-18T23:26:44.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page revision from v3.2.0 to v3.3.2 did not change the study details or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-27T04:31:06.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The government funding lapse notice banner was removed from the page, eliminating the banner that previously warned about potential delays and operating status updates.
    Difference
    0.3%
    Check dated 2025-11-19T22:14:36.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    No significant additions or deletions detected; the study overview, eligibility criteria, and planned outcomes appear unchanged.
    Difference
    0.4%
    Check dated 2025-10-29T10:05:17.000Z thumbnail image
  9. Check
    102 days ago
    Change Detected
    Summary
    - Added a prominent funding/status notice and updated to revision v3.2.0. - Removed the previous revision reference v3.1.0.
    Difference
    3%
    Check dated 2025-10-07T23:20:16.000Z thumbnail image

Stay in the know with updates to CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab

Enter your email address, and we'll notify you when there's something new on the CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab page.